HLB Therapeutics Co.,Ltd.
115450
Rang in aandelen
#18716
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Aandeelprijs
$1.87
Marktkapitalisatie
$176.28M
Verandering (1 dag)
-0.55%
Verandering (1 jaar)
-10.80%
Land
KR
Handel HLB Therapeutics Co.,Ltd. (115450)
Categorie
Healthcare
Marktkapitalisatie van HLB Therapeutics Co.,Ltd.(115450)
Marktkapitalisatie: $176.28M
Vanaf October 2026 heeft HLB Therapeutics Co.,Ltd. een marktkapitalisatie van $176.28M. Dit maakt HLB Therapeutics Co.,Ltd. volgens onze gegevens het 18716th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van HLB Therapeutics Co.,Ltd. van 2010 tot 2026
115450 vergeleken met de top 5 populairste stocks
| Prijs voor 115450 | Aandeel B | Marktkapitalisatie van B | uitslagen | |
|---|---|---|---|---|
$55,350.20
$176.28M
|
$5.216T | +2,959,028.38% | ||
|
$52,543.40
$176.28M
|
$4.952T | +2,808,971.32% | ||
|
$43,481.18
$176.28M
|
$4.098T | +2,324,487.73% | ||
|
$41,821.20
$176.28M
|
$3.941T | +2,235,741.82% | ||
|
$30,017.71
$176.28M
|
$2.829T | +1,604,704.52% |
